Literature DB >> 6339002

Chronic demyelinating neuropathy associated with benign IgM paraproteinaemia.

I S Smith, S N Kahn, B W Lacey, R H King, R A Eames, D J Whybrew, P K Thomas.   

Abstract

Twelve cases of chronic sensorimotor neuropathy associated with benign IgM paraproteinaemia are described. The onset was in the sixth or seventh decades and 9 cases were male. Tremor and ataxia were common features. The ESR was raised in 6 cases and the CSF protein content elevated in 10. There was severe reduction of motor nerve conduction velocity. Sera from all cases contained monoclonal IgM antibodies strongly reactive with human peripheral myelin, made up by the paraprotein. Histological studies on nerve biopsies taken from 8 cases all demonstrated a demyelinating neuropathy. Eight biopsies were examined by immunofluorescence. Monoclonal IgM was present on the myelin sheaths of surviving myelinated nerve fibres. The findings suggested that the neuropathy was of autoimmune origin and caused directly by the antimyelin antibody.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6339002     DOI: 10.1093/brain/106.1.169

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  35 in total

1.  A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group.

Authors:  X Mariette; C Chastang; P Clavelou; J P Louboutin; J M Leger; J C Brouet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

2.  [Polyneuropathies in monoclonal gammopathy of undetermined significance: initial manifestation of a lymphoma].

Authors:  C Drees; M Grond; B Szelies; M Dietlein; B Salzberger; V Diehl; W D Heiss
Journal:  Med Klin (Munich)       Date:  1997-02-15

Review 3.  Monoclonal antibodies to myelin-associated glycoprotein reveal antigenic structures and suggest pathogenic mechanisms.

Authors:  A J Steck; N Murray
Journal:  Springer Semin Immunopathol       Date:  1985

Review 4.  Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.

Authors:  Norman Latov
Journal:  Nat Rev Neurol       Date:  2014-07-01       Impact factor: 42.937

5.  Reactivity of sera and isolated monoclonal IgM from patients with Waldenström's macroglobulinaemia with peripheral nerve myelin.

Authors:  H Harbs; M Arfmann; E Frick; C Hörmann; U Wurster; U Patzold; E Stark; H Deicher
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

6.  The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings.

Authors:  K B Yeung; P K Thomas; R H King; H Waddy; R G Will; R A Hughes; N A Gregson; S Leibowitz
Journal:  J Neurol       Date:  1991-10       Impact factor: 4.849

7.  IgM-monoclonal gammopathy neuropathy and tremor: a first epidemiologic case control study.

Authors:  Matthew C Ahlskog; Neeraj Kumar; Michelle L Mauermann; Christopher J Klein
Journal:  Parkinsonism Relat Disord       Date:  2012-04-03       Impact factor: 4.891

8.  Polyneuropathy associated with IgM monoclonal gammopathy. Immunological and pathological study in 31 patients.

Authors:  A Vital; C Vital; J Julien; A Baquey; A J Steck
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 9.  Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy.

Authors:  J M Leger; A B Younes-Chennoufi; B Chassande; G Davila; P Bouche; N Baumann; P Brunet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

10.  Extensive demyelinating changes in the peripheral nerves of Crow-Fukase syndrome: a pathological study of one autopsied case.

Authors:  G Sobue; M Doyu; M Watanabe; F Hayashi; T Mitsuma
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.